A 2020 network meta-analysis of data from more than 11,000 patients concluded that, compared with TT (as the reference), the odds ratios for thrombosis in myocardial infarction (TIMI) major bleeding were 0.52 for DOAC plus P2Y12 inhibitor [17]. This evidence concerns the gene P2RY12 and myocardial infarction.